{ 'indexed': {'date-parts': [[2023, 9, 22]], 'date-time': '2023-09-22T05:20:28Z', 'timestamp': 1695360028018},
'reference-count': 49,
'publisher': 'Elsevier BV',
'license': [ { 'start': { 'date-parts': [[2023, 9, 1]],
'date-time': '2023-09-01T00:00:00Z',
'timestamp': 1693526400000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'},
{ 'start': { 'date-parts': [[2023, 9, 1]],
'date-time': '2023-09-01T00:00:00Z',
'timestamp': 1693526400000},
'content-version': 'stm-asf',
'delay-in-days': 0,
'URL': 'https://doi.org/10.15223/policy-017'},
{ 'start': { 'date-parts': [[2023, 9, 1]],
'date-time': '2023-09-01T00:00:00Z',
'timestamp': 1693526400000},
'content-version': 'stm-asf',
'delay-in-days': 0,
'URL': 'https://doi.org/10.15223/policy-037'},
{ 'start': { 'date-parts': [[2023, 9, 1]],
'date-time': '2023-09-01T00:00:00Z',
'timestamp': 1693526400000},
'content-version': 'stm-asf',
'delay-in-days': 0,
'URL': 'https://doi.org/10.15223/policy-012'},
{ 'start': { 'date-parts': [[2023, 9, 1]],
'date-time': '2023-09-01T00:00:00Z',
'timestamp': 1693526400000},
'content-version': 'stm-asf',
'delay-in-days': 0,
'URL': 'https://doi.org/10.15223/policy-029'},
{ 'start': { 'date-parts': [[2023, 9, 1]],
'date-time': '2023-09-01T00:00:00Z',
'timestamp': 1693526400000},
'content-version': 'stm-asf',
'delay-in-days': 0,
'URL': 'https://doi.org/10.15223/policy-004'}],
'content-domain': {'domain': ['elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True},
'published-print': {'date-parts': [[2023, 9]]},
'DOI': '10.1016/j.idairyj.2023.105805',
'type': 'journal-article',
'created': {'date-parts': [[2023, 9, 21]], 'date-time': '2023-09-21T23:45:27Z', 'timestamp': 1695339927000},
'page': '105805',
'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Bovine lactoferrin suppresses the cathepsin-dependent pathway of SARS-CoV-2 entry in vitro',
'prefix': '10.1016',
'author': [ { 'ORCID': 'http://orcid.org/0000-0001-7472-2565',
'authenticated-orcid': False,
'given': 'Michiyo',
'family': 'Kobayashi-Sakamoto',
'sequence': 'first',
'affiliation': []},
{'given': 'Maeda', 'family': 'Toyonobu', 'sequence': 'additional', 'affiliation': []},
{'given': 'Junko', 'family': 'Yusa', 'sequence': 'additional', 'affiliation': []},
{'given': 'Takahisa', 'family': 'Shimada', 'sequence': 'additional', 'affiliation': []},
{'given': 'Hideki', 'family': 'Tani', 'sequence': 'additional', 'affiliation': []},
{'given': 'Yasumasa', 'family': 'Kato', 'sequence': 'additional', 'affiliation': []},
{'given': 'Kimiharu', 'family': 'Hirose', 'sequence': 'additional', 'affiliation': []}],
'member': '78',
'reference': [ { 'key': '10.1016/j.idairyj.2023.105805_bib1',
'doi-asserted-by': 'crossref',
'DOI': '10.3390/medicina57080842',
'article-title': 'The prospect of lactoferrin use as adjunctive agent in management of '
'SARS-CoV-2 patients: A randomized pilot study',
'volume': '57',
'author': 'Algahtani',
'year': '2021',
'journal-title': 'Medicina'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib2',
'doi-asserted-by': 'crossref',
'DOI': '10.15252/embj.2020106765',
'article-title': 'Infection and transmission of SARS-CoV-2 depend on heparan sulfate '
'proteoglycans',
'volume': '40',
'author': 'Bermejo-Jambrina',
'year': '2021',
'journal-title': 'EMBO Journal'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib3',
'doi-asserted-by': 'crossref',
'DOI': '10.3390/ijerph182010985',
'article-title': 'Lactoferrin as antiviral treatment in COVID-19 management: preliminary '
'evidence',
'volume': '18',
'author': 'Campione',
'year': '2021',
'journal-title': 'International Journal of Environmental Research and Public Health'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib4',
'doi-asserted-by': 'crossref',
'DOI': '10.3390/nu14245274',
'article-title': 'Can lactoferrin, a natural mammalian milk protein, assist in the battle '
'against COVID-19?',
'volume': '14',
'author': 'Einerhand',
'year': '2022',
'journal-title': 'Nutrients'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib5',
'doi-asserted-by': 'crossref',
'first-page': '2269',
'DOI': '10.1099/vir.0.80955-0',
'article-title': 'Vesicular stomatitis virus pseudotyped with severe acute respiratory '
'syndrome coronavirus spike protein',
'volume': '86',
'author': 'Fukushi',
'year': '2005',
'journal-title': 'Journal of General Virology'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib6',
'doi-asserted-by': 'crossref',
'DOI': '10.3389/fviro.2022.849936',
'article-title': 'Alpha, beta, delta, omicron, and SARS-CoV-2 breakthrough cases: '
'Defining immunological mechanisms for vaccine waning and '
'vaccine-variant mismatch',
'volume': '2',
'author': 'Hewins',
'year': '2022',
'journal-title': 'Frontiers in Virology'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib7',
'doi-asserted-by': 'crossref',
'first-page': '271',
'DOI': '10.1016/j.cell.2020.02.052',
'article-title': 'SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a '
'clinically proven protease inhibitor',
'volume': '181',
'author': 'Hoffmann',
'year': '2020',
'journal-title': 'Cell'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib8',
'doi-asserted-by': 'crossref',
'first-page': '317',
'DOI': '10.1080/22221751.2021.1888660',
'article-title': 'The in vitro antiviral activity of lactoferrin against common human '
'coronaviruses and SARS-CoV-2 is mediated by targeting the heparan '
'sulfate co-receptor',
'volume': '10',
'author': 'Hu',
'year': '2021',
'journal-title': 'Emerging Microbes & Infections'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib9',
'doi-asserted-by': 'crossref',
'first-page': '293',
'DOI': '10.1038/s41423-021-00836-z',
'article-title': 'Increased immune escape of the new SARS-CoV-2 variant of concern '
'Omicron',
'volume': '19',
'author': 'Hu',
'year': '2022',
'journal-title': 'Cellular & Molecular Immunology'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib10',
'doi-asserted-by': 'crossref',
'first-page': '497',
'DOI': '10.1016/S0140-6736(20)30183-5',
'article-title': 'Clinical features of patients infected with 2019 novel coronavirus in '
'Wuhan, China',
'volume': '395',
'author': 'Huang',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib11',
'doi-asserted-by': 'crossref',
'first-page': '715',
'DOI': '10.1038/s41586-022-04479-6',
'article-title': 'SARS-CoV-2 Omicron variant replication in human bronchus and lung ex '
'vivo',
'volume': '603',
'author': 'Hui',
'year': '2022',
'journal-title': 'Nature'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib12',
'doi-asserted-by': 'crossref',
'first-page': '29',
'DOI': '10.1016/bs.aivir.2016.08.004',
'article-title': 'Coronavirus spike protein and tropism changes',
'volume': '96',
'author': 'Hulswit',
'year': '2016',
'journal-title': 'Advances in Virus Research'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib13',
'doi-asserted-by': 'crossref',
'first-page': '51',
'DOI': '10.1016/S0168-1702(99)00121-5',
'article-title': 'Characterization of antiviral activity of lactoferrin against hepatitis '
'C virus infection in human cultured cells',
'volume': '66',
'author': 'Ikeda',
'year': '2000',
'journal-title': 'Virus Research'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib14',
'doi-asserted-by': 'crossref',
'first-page': '2234',
'DOI': '10.1016/j.vaccine.2023.02.068',
'article-title': 'Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose '
'of COVID-19 mRNA vaccine in a Japanese nursing home cohort',
'volume': '41',
'author': 'Itamochi',
'year': '2023',
'journal-title': 'Vaccine'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib15',
'doi-asserted-by': 'crossref',
'first-page': '282',
'DOI': '10.4062/biomolther.2020.201',
'article-title': 'Discovery of new fusion inhibitor peptides against SARS-CoV-2 by '
'targeting the spike S2 subunit',
'volume': '29',
'author': 'Kandeel',
'year': '2021',
'journal-title': 'Biomolecular Therapy'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib16',
'doi-asserted-by': 'crossref',
'first-page': '712',
'DOI': '10.1128/JVI.01933-08',
'article-title': 'Protease-mediated entry via the endosome of human coronavirus 229E',
'volume': '83',
'author': 'Kawase',
'year': '2009',
'journal-title': 'Journal of Virology'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib17',
'doi-asserted-by': 'crossref',
'first-page': '147',
'DOI': '10.1002/jmv.27282',
'article-title': 'SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly '
'associated with disease severity and mortality in patients with '
'COVID-19',
'volume': '94',
'author': 'Kawasuji',
'year': '2022',
'journal-title': 'Journal of Medical Virology'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib18',
'article-title': 'The biology of lactoferrin, an iron-binding protein that can help '
'defend against viruses and bacteria',
'volume': '1221',
'author': 'Kell',
'year': '2020',
'journal-title': 'Frontiers in Immunology'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib19',
'doi-asserted-by': 'crossref',
'first-page': '103',
'DOI': '10.1007/s00430-022-00760-7',
'article-title': 'Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, '
'Omicron and viruses with D614G plus key signature mutations in spike '
'protein alters fusogenicity and infectivity',
'volume': '212',
'author': 'Khatri',
'year': '2023',
'journal-title': 'Medical Microbiology and Immunology'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib20',
'doi-asserted-by': 'crossref',
'first-page': '338',
'DOI': '10.1139/bcb-2021-0342',
'article-title': 'Bovine lactoferrin increases the poly(I:C)-induced antiviral response '
'in vitro',
'volume': '100',
'author': 'Kobayashi-Sakamoto',
'year': '2022',
'journal-title': 'Biochemistry and Cell Biology'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib21',
'doi-asserted-by': 'crossref',
'first-page': '27',
'DOI': '10.20965/jdr.2023.p0027',
'article-title': 'Lactoferrin as a possible preventive and therapeutic agent against '
'SARS-CoV-2 infection',
'volume': '18',
'author': 'Kobayashi-Sakamoto',
'year': '2023',
'journal-title': 'Journal of Disaster Research'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib22',
'doi-asserted-by': 'crossref',
'DOI': '10.15252/embj.2021107821',
'article-title': 'TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to '
'infect host cells',
'volume': '40',
'author': 'Koch',
'year': '2021',
'journal-title': 'EMBO Journal'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib23',
'doi-asserted-by': 'crossref',
'DOI': '10.1371/journal.pone.0023710',
'article-title': 'Inhibition of SARS pseudovirus cell entry by lactoferrin binding to '
'heparan sulfate proteoglycans',
'volume': '6',
'author': 'Lang',
'year': '2011',
'journal-title': 'PloS One'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib24',
'doi-asserted-by': 'crossref',
'DOI': '10.1371/journal.ppat.1009500',
'article-title': 'The SARS-CoV-2 and other human coronavirus spike proteins are '
'fine-tuned towards temperature and proteases of the human airways',
'volume': '17',
'author': 'Laporte',
'year': '2021',
'journal-title': 'PLoS Pathogens'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib25',
'doi-asserted-by': 'crossref',
'unstructured': 'Li, C., Huang, J., Yu, Y., Wan, Z., Chiu, M. C., Liu, X., et al. (2023). '
'Human airway and nasal organoids reveal escalating replicative fitness '
'of SARS-CoV-2 emerging variants. Proceedings of the National Academy of '
'Sciences, USA, 120, Article e2300376120.',
'DOI': '10.1073/pnas.2300376120'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib26',
'doi-asserted-by': 'crossref',
'DOI': '10.3390/nu15051285',
'article-title': 'Effect of lactoferrin on clinical outcomes of hospitalized patients '
'with COVID-19: The LAC randomized clinical trial',
'volume': '15',
'author': 'Matino',
'year': '2023',
'journal-title': 'Nutrients'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib27',
'doi-asserted-by': 'crossref',
'first-page': '706',
'DOI': '10.1038/s41586-022-04474-x',
'article-title': 'Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and '
'fusogenicity',
'volume': '603',
'author': 'Meng',
'year': '2022',
'journal-title': 'Nature'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib28',
'doi-asserted-by': 'crossref',
'unstructured': 'Mirabelli, C., Wotring, J. W., Zhang, C. J., McCarty, S. M., Fursmidt, '
'R., Pretto, C. D., et al. (2021). Morphological cell profiling of '
'SARS-CoV-2 infection identifies drug repurposing candidates for '
'COVID-19. Proceedings of the National Academy of Sciences, USA, 118, '
'Article e2105815118.',
'DOI': '10.1101/2020.05.27.117184'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib29',
'doi-asserted-by': 'crossref',
'first-page': '463',
'DOI': '10.1007/s10534-022-00477-3',
'article-title': 'Bovine lactoferrin for the prevention of COVID-19 infection in health '
'care personnel: a double-blinded randomized clinical trial (LF-COVID)',
'volume': '36',
'author': 'Navarro',
'year': '2023',
'journal-title': 'Biometals'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib30',
'doi-asserted-by': 'crossref',
'first-page': '98',
'DOI': '10.1016/S0006-291X(03)00917-3',
'article-title': 'New functions of lactoferrin and β-casein in mammalian milk as cysteine '
'protease inhibitors',
'volume': '306',
'author': 'Ohashi',
'year': '2003',
'journal-title': 'Biochemical and Biophysical Research Communications'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib31',
'doi-asserted-by': 'crossref',
'DOI': '10.1080/19420862.2022.2072455',
'article-title': 'Novel super-neutralizing antibody UT28K is capable of protecting '
'against infection from a wide variety of SARS-CoV-2 variants',
'volume': '14',
'author': 'Ozawa',
'year': '2022',
'journal-title': 'mAbs'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib32',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.jtbi.2023.111568',
'article-title': 'Modelling how increased cathepsin B/L and decreased TMPRSS2 usage for '
'cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy '
'and synergy of TMPRSS2 and cathepsin B/L inhibitors',
'volume': '572',
'author': 'Padmanabhan',
'year': '2023',
'journal-title': 'Journal of Theoretical Biology'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib33',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.idairyj.2022.105488',
'article-title': 'Hydrolysis improves the inhibition efficacy of bovine lactoferrin '
'against infection by SARS-CoV-2 pseudovirus',
'volume': '137',
'author': 'Patil',
'year': '2023',
'journal-title': 'International Dairy Journal'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib34',
'doi-asserted-by': 'crossref',
'first-page': '345',
'DOI': '10.1038/d41586-020-02379-1',
'article-title': 'COVID-19 poses a riddle for the immune system',
'volume': '584',
'author': 'Perlman',
'year': '2020',
'journal-title': 'Nature'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib35',
'doi-asserted-by': 'crossref',
'DOI': '10.1371/journal.ppat.1009013',
'article-title': 'The role of cysteine peptidases in coronavirus cell entry and '
'replication: The therapeutic potential of cathepsin inhibitors',
'volume': '16',
'author': 'Pišlar',
'year': '2020',
'journal-title': 'PLoS Pathogens'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib36',
'doi-asserted-by': 'crossref',
'DOI': '10.15252/embj.2021108944',
'article-title': 'SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced '
'spike-mediated syncytia formation',
'volume': '40',
'author': 'Rajah',
'year': '2021',
'journal-title': 'EMBO Journal'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib37',
'doi-asserted-by': 'crossref',
'first-page': '581',
'DOI': '10.1016/j.crvi.2014.08.003',
'article-title': 'Potential lactoferrin activity against pathogenic viruses',
'volume': '337',
'author': 'Redwan',
'year': '2014',
'journal-title': 'Comptes Rendus Biologies'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib38',
'doi-asserted-by': 'crossref',
'DOI': '10.3390/jcm10184276',
'article-title': 'Ambulatory COVID-19 patients treated with lactoferrin as a '
'supplementary antiviral agent: a preliminary study',
'volume': '10',
'author': 'Rosa',
'year': '2021',
'journal-title': 'Journal of Clinical Medicine'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib39',
'doi-asserted-by': 'crossref',
'DOI': '10.3390/nu13020328',
'article-title': 'Protective effects of lactoferrin against SARS-CoV-2 infection in vitro',
'volume': '13',
'author': 'Salaris',
'year': '2021',
'journal-title': 'Nutrients'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib40',
'doi-asserted-by': 'crossref',
'first-page': '2806',
'DOI': '10.1016/j.csbj.2021.05.002',
'article-title': 'Evidence of a putative glycosaminoglycan binding site on the '
'glycosylated SARS-CoV-2 spike protein N-terminal domain',
'volume': '19',
'author': 'Schuurs',
'year': '2021',
'journal-title': 'Computational and Structural Biotechnology Journal'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib41',
'doi-asserted-by': 'crossref',
'first-page': '640',
'DOI': '10.1038/d41586-021-02039-y',
'article-title': 'How the coronavirus infects cells-and why Delta is so dangerous',
'volume': '595',
'author': 'Scudellari',
'year': '2021',
'journal-title': 'Nature'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib42',
'doi-asserted-by': 'crossref',
'DOI': '10.1002/rmv.2381',
'article-title': 'Evolution of the SARS‐CoV‐2 omicron variants BA. 1 to BA. 5: '
'implications for immune escape and transmission',
'volume': '32',
'author': 'Shrestha',
'year': '2022',
'journal-title': 'Reviews in Medical Virology'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib43',
'article-title': 'Characterization of SARS-CoV-2 variants N501Y.V1 and N501Y.V2 spike on '
'viral infectivity',
'volume': '11',
'author': 'Tang',
'year': '2021',
'journal-title': 'Frontiers in Cell Infection and Microbiology'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib44',
'doi-asserted-by': 'crossref',
'DOI': '10.1186/s12985-021-01490-7',
'article-title': 'Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular '
'stomatitis virus possessing SARS-CoV-2 spike protein',
'volume': '18',
'author': 'Tani',
'year': '2021',
'journal-title': 'Virology Journal'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib45',
'doi-asserted-by': 'crossref',
'first-page': '666',
'DOI': '10.1016/j.jiac.2014.08.003',
'article-title': 'Lactoferrin for prevention of common viral infections',
'volume': '20',
'author': 'Wakabayashi',
'year': '2014',
'journal-title': 'Journal of Infection Chemotherapy'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib46',
'article-title': 'A novel hamster model of SARS-CoV-2 respiratory infection using a '
'pseudotyped virus',
'volume': '12',
'author': 'Yamada',
'year': '2022',
'journal-title': 'Science Reports'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib47',
'doi-asserted-by': 'crossref',
'DOI': '10.1038/s41598-023-35915-w',
'article-title': 'Evaluation of SARS-CoV-2 isolation in cell culture from '
'nasal/nasopharyngeal swabs or saliva specimens of patients with '
'COVID-19',
'volume': '13',
'author': 'Yazawa',
'year': '2023',
'journal-title': 'Scientific Reports'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib48',
'doi-asserted-by': 'crossref',
'first-page': '739',
'DOI': '10.1016/j.cell.2020.09.032',
'article-title': 'Structural and functional analysis of the D614G SARS-CoV-2 spike '
'protein variant',
'volume': '183',
'author': 'Yurkovetskiy',
'year': '2020',
'journal-title': 'Cell'},
{ 'key': '10.1016/j.idairyj.2023.105805_bib49',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.intimp.2021.107571',
'article-title': 'The potential for lactoferrin to reduce SARS-CoV-2 induced cytokine '
'storm',
'volume': '95',
'author': 'Zimecki',
'year': '2021',
'journal-title': 'International Immunopharmacology'}],
'container-title': 'International Dairy Journal',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0958694623002248?httpAccept=text/xml',
'content-type': 'text/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://api.elsevier.com/content/article/PII:S0958694623002248?httpAccept=text/plain',
'content-type': 'text/plain',
'content-version': 'vor',
'intended-application': 'text-mining'}],
'deposited': { 'date-parts': [[2023, 9, 21]],
'date-time': '2023-09-21T23:45:49Z',
'timestamp': 1695339949000},
'score': 1,
'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0958694623002248'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2023, 9]]},
'references-count': 49,
'alternative-id': ['S0958694623002248'],
'URL': 'http://dx.doi.org/10.1016/j.idairyj.2023.105805',
'relation': {},
'ISSN': ['0958-6946'],
'subject': ['Applied Microbiology and Biotechnology', 'Food Science'],
'container-title-short': 'International Dairy Journal',
'published': {'date-parts': [[2023, 9]]},
'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'},
{ 'value': 'Bovine lactoferrin suppresses the cathepsin-dependent pathway of SARS-CoV-2 '
'entry in vitro',
'name': 'articletitle',
'label': 'Article Title'},
{'value': 'International Dairy Journal', 'name': 'journaltitle', 'label': 'Journal Title'},
{ 'value': 'https://doi.org/10.1016/j.idairyj.2023.105805',
'name': 'articlelink',
'label': 'CrossRef DOI link to publisher maintained version'},
{'value': 'article', 'name': 'content_type', 'label': 'Content Type'},
{ 'value': '© 2023 Elsevier Ltd. All rights reserved.',
'name': 'copyright',
'label': 'Copyright'}],
'article-number': '105805'}
